Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)

NCT06313190 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

RADIATION: Stereotactic body radiotherapy
DRUG: Sintilimab

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]